Intuitive(US:ISRG) investorplace.comยท2024-05-28 18:15Industry Overview - The medical technology sector is gaining attention alongside biotechnology, with significant potential for improving patient outcomes [1] - The global medical device technology market was valued at $639.1 billion in 2021 and is projected to reach $953.4 billion by 2027, representing a compound annual growth rate (CAGR) of 7.1% [1] Company Analysis: Johnson & Johnson (JNJ) - Johnson & Johnson operates in both drug manufacturing and medical technology, providing solutions for heart rhythm disorders and neurovascular care [2] - Analysts rate JNJ as a moderate buy with an average price target of $175.21, with a high forecast of $215 per share [2] - In the trailing 12 months, JNJ reported net income of $17.07 billion on revenue of $85.68 billion, with projected earnings per share growth of 7.36% for fiscal 2024 [3] Company Analysis: Intuitive Surgical (ISRG) - Intuitive Surgical specializes in medical instruments and is known for its da Vinci Surgical System, enhancing minimally invasive care [5] - Analysts have a consensus strong buy rating for ISRG, with an average price target of $427.93 and an optimistic target of $475 per share [5] - The company achieved net income of $1.99 billion on sales of $7.32 billion in the trailing 12 months, with expected EPS growth of 10% for fiscal 2024 [6] Company Analysis: Stryker (SYK) - Stryker focuses on orthopedics and spinal business, providing implants for joint replacements and surgical equipment [7] - Analysts rate SYK as a strong buy with an average price target of $382.06, indicating about 14% upside potential [7] - In the trailing 12 months, Stryker reported net income of $3.36 billion on revenue of $20.96 billion, with projected EPS growth of 12.8% for fiscal 2024 [8]